The role of NAT1 in breast cancer, until recently, was thought to center on NAT1’s ability to metabolize/activate carcinogens, however it has been shown that rats with higher Nat2 expression (orthologous to human NAT1) had greater mammary tumor susceptibility, independent of carcinogen metabolism (Stepp et al., 2017). This evidence concerns the gene NAT2 and breast cancer.